We came across a bullish thesis on Journey Medical Corporation (DERM) on Substack by The 10x Radar. In this article, we will ...
Gen Z is out to transform Europe’s food system, with five teams of young innovators taking home a share of €25k (£20.6k) in prize money at this year’s Menu for Change challenge.
The importance of what one chooses to take along on fishing trips cannot be overstated, nor can words adequately describe ...
Apellis and Sobi have global co-development rights for systemic pegcetacoplan. Sobi has exclusive ex-U.S. commercialization rights for systemic pegcetacoplan, and Apellis has exclusive U.S.
US Dollar Japanese Yen, US Dollar Index Futures, Japan 2-Year. Read David Scutt's latest article on Investing.com ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results